Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin

Lancet (London, England)
|February 1, 1975
PubMed

Insights

A multidrug-resistant Salmonella typhimurium strain emerged in a burn unit, spreading person-to-person. This silver nitrate-resistant pathogen poses a significant threat due to its resistance to key antibiotics.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • A specific strain of Salmonella typhimurium was identified in three patients within a burn unit.
  • Epidemiological data suggested person-to-person transmission of the organism.
  • The patients experienced both colonization and invasive infections.

Purpose of the Study:

  • To investigate the characteristics of a unique Salmonella typhimurium strain found in a burn unit.
  • To determine the antibiotic and metal ion susceptibility of the identified strain.
  • To assess the transferability of resistance patterns and the implications for burn wound management.

Main Methods:

  • Epidemiological investigation of patient cases.
  • In vitro antibiotic and metal ion susceptibility testing.
  • In vitro mating experiments to assess resistance transfer between bacterial strains.

Main Results:

  • The isolated Salmonella typhimurium strain exhibited resistance to silver nitrate, mercuric chloride, ampicillin, chloramphenicol, tetracycline, streptomycin, and sulphonamides.
  • This resistance pattern was transferable to sensitive strains of Escherichia coli and Salmonella typhimurium via in vitro mating.
  • Other Salmonella strains from non-burn patients and geographically distinct S. typhimurium strains did not share this complete resistance profile.

Conclusions:

  • The emergence of this multidrug-resistant Salmonella typhimurium in burn units presents a serious clinical challenge.
  • Topical treatments like silver nitrate may inadvertently select for resistant strains, exacerbating the threat.
  • The resistance to ampicillin and chloramphenicol, crucial systemic antibiotics, combined with topical resistance, highlights a critical public health concern in burn care settings.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...